< Back to Article

A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever

Fig 1

Subject completion flow chart.

doi: https://doi.org/10.1371/journal.pntd.0007912.g001